Cantor Fitzgerald Analyst Ratings & Stock Recommendations

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Cantor Fitzgerald. These ratings and price targets were collected from pubilc media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Cantor Fitzgerald.

DateBrokerageActionCompany
Name
RatingPrice
Target
Impact on
Share Price
Actions
1/21/2019Cantor FitzgeraldReiteratesTherapeuticsMD (TXMD)Buy $27.00N/AView Rating Details  Share on Twitter  Share on StockTwits
1/18/2019Cantor FitzgeraldSet Price TargetZimmer Biomet (ZBH)Buy $135.00N/AView Rating Details  Share on Twitter  Share on StockTwits
1/18/2019Cantor FitzgeraldSet Price TargetGlobus Medical (GMED)Buy $60.00N/AView Rating Details  Share on Twitter  Share on StockTwits
1/18/2019Cantor FitzgeraldSet Price TargetOrthofix Medical (OFIX)Buy $60.00N/AView Rating Details  Share on Twitter  Share on StockTwits
1/18/2019Cantor FitzgeraldSet Price TargetAxoGen (AXGN)Buy $26.00N/AView Rating Details  Share on Twitter  Share on StockTwits
1/15/2019Cantor FitzgeraldReiteratesZimmer Biomet (ZBH)OverweightN/AView Rating Details  Share on Twitter  Share on StockTwits
1/18/2019Cantor FitzgeraldRaises TargetWNS (WNS)Outperform -> Overweight $61.00MediumView Rating Details  Share on Twitter  Share on StockTwits
1/18/2019Cantor FitzgeraldInitiatesAerpio Pharmaceuticals (ARPO)Overweight $8.00HighView Rating Details  Share on Twitter  Share on StockTwits
1/16/2019Cantor FitzgeraldReiteratesIBM (IBM)Hold $140.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/16/2019Cantor FitzgeraldReiteratesFiserv (FISV)Hold $73.00HighView Rating Details  Share on Twitter  Share on StockTwits
1/16/2019Cantor FitzgeraldReiteratesAptinyx (APTX)Buy $40.00HighView Rating Details  Share on Twitter  Share on StockTwits
1/15/2019Cantor FitzgeraldReiteratesExponent (EXPO)Buy $56.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/15/2019Cantor FitzgeraldReiteratesIHS Markit (INFO)Hold $51.00HighView Rating Details  Share on Twitter  Share on StockTwits
1/15/2019Cantor FitzgeraldInitiatesArray Biopharma (ARRY)Overweight $30.00HighView Rating Details  Share on Twitter  Share on StockTwits
1/15/2019Cantor FitzgeraldReiteratesUnitedHealth Group (UNH)Buy $310.00HighView Rating Details  Share on Twitter  Share on StockTwits
1/14/2019Cantor FitzgeraldReiteratesHTG Molecular Diagnostics (HTGM)Buy $7.00MediumView Rating Details  Share on Twitter  Share on StockTwits
1/14/2019Cantor FitzgeraldSet Price TargetKindred Biosciences (KIN)Buy $25.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/14/2019Cantor FitzgeraldSet Price TargetWright Medical Group (WMGI)Buy $35.00MediumView Rating Details  Share on Twitter  Share on StockTwits
1/14/2019Cantor FitzgeraldReiteratesInvesco DWA Utilities Momentum ETF (PTE)Buy $65.00MediumView Rating Details  Share on Twitter  Share on StockTwits
1/13/2019Cantor FitzgeraldReiteratesCoupa Software (COUP)Buy $92.00MediumView Rating Details  Share on Twitter  Share on StockTwits
1/13/2019Cantor FitzgeraldReiteratesFactSet Research Systems (FDS)Hold $209.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/10/2019Cantor FitzgeraldSet Price TargetSupernus Pharmaceuticals (SUPN)Buy $57.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/11/2019Cantor FitzgeraldReiteratesInfosys (INFY)Hold $10.00HighView Rating Details  Share on Twitter  Share on StockTwits
1/11/2019Cantor FitzgeraldReiteratesCorbus Pharmaceuticals (CRBP)Overweight -> Overweight$36.00 -> $38.00HighView Rating Details  Share on Twitter  Share on StockTwits
1/11/2019Cantor FitzgeraldReiteratesVocera Communications (VCRA)Overweight $45.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/10/2019Cantor FitzgeraldReiteratesSpark Therapeutics (ONCE)Overweight -> Overweight$103.00 -> $80.00MediumView Rating Details  Share on Twitter  Share on StockTwits
1/10/2019Cantor FitzgeraldReiteratesNightstar Therapeutics (NITE)Overweight -> Overweight$36.00 -> $42.00HighView Rating Details  Share on Twitter  Share on StockTwits
1/9/2019Cantor FitzgeraldReiteratesAridis Pharmaceuticals (ARDS)Buy $25.00MediumView Rating Details  Share on Twitter  Share on StockTwits
1/9/2019Cantor FitzgeraldReiteratesGlobus Medical (GMED)Buy $65.00HighView Rating Details  Share on Twitter  Share on StockTwits
1/8/2019Cantor FitzgeraldSet Price TargetIntegra Lifesciences (IART)Hold $54.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/8/2019Cantor FitzgeraldSet Price TargetOrthofix Medical (OFIX)Buy $66.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/8/2019Cantor FitzgeraldReiteratesRigel Pharmaceuticals (RIGL)Buy $9.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/7/2019Cantor FitzgeraldReiteratesPTC Therapeutics (PTCT)Buy $61.00HighView Rating Details  Share on Twitter  Share on StockTwits
1/7/2019Cantor FitzgeraldReiteratesDXC Technology (DXC)Hold $70.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/7/2019Cantor FitzgeraldReiteratesCollegium Pharmaceutical (COLL)Buy $35.00HighView Rating Details  Share on Twitter  Share on StockTwits
1/7/2019Cantor FitzgeraldReiteratesBioMarin Pharmaceutical (BMRN)Buy $126.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/7/2019Cantor FitzgeraldReiteratesSeaSpine (SPNE)Buy $22.00MediumView Rating Details  Share on Twitter  Share on StockTwits
1/7/2019Cantor FitzgeraldReiteratesTeladoc Health (TDOC)Hold $83.00HighView Rating Details  Share on Twitter  Share on StockTwits
1/4/2019Cantor FitzgeraldSet Price TargetEmergent Biosolutions (EBS)Buy $75.00HighView Rating Details  Share on Twitter  Share on StockTwits
1/4/2019Cantor FitzgeraldSet Price TargetAllergan (AGN)Hold $180.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/4/2019Cantor FitzgeraldSet Price TargetJazz Pharmaceuticals (JAZZ)Buy $201.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/3/2019Cantor FitzgeraldReiteratesCVS Health (CVS)Buy $96.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/3/2019Cantor FitzgeraldReiteratesCelgene (CELG)Buy $100.00HighView Rating Details  Share on Twitter  Share on StockTwits
1/2/2019Cantor FitzgeraldReiteratesHumana (HUM)Hold $325.00HighView Rating Details  Share on Twitter  Share on StockTwits
1/2/2019Cantor FitzgeraldSet Price TargetAcorda Therapeutics (ACOR)Hold $32.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/31/2018Cantor FitzgeraldReiteratesHeron Therapeutics (HRTX)Buy $50.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/31/2018Cantor FitzgeraldReiteratesEvolent Health (EVH)Buy $37.00LowView Rating Details  Share on Twitter  Share on StockTwits
12/26/2018Cantor FitzgeraldSet Price TargetNeos Therapeutics (NEOS)Buy $20.00LowView Rating Details  Share on Twitter  Share on StockTwits
12/26/2018Cantor FitzgeraldSet Price TargetAllergan (AGN)Hold $180.00LowView Rating Details  Share on Twitter  Share on StockTwits
12/26/2018Cantor FitzgeraldSet Price TargetMarinus Pharmaceuticals (MRNS)Buy $22.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/27/2018Cantor FitzgeraldSet Price TargetBioDelivery Sciences International (BDSI)Buy $5.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/28/2018Cantor FitzgeraldSet Price TargetAmarin (AMRN)Buy $35.00MediumView Rating Details  Share on Twitter  Share on StockTwits
12/28/2018Cantor FitzgeraldSet Price TargetAclaris Therapeutics (ACRS)Buy $50.00LowView Rating Details  Share on Twitter  Share on StockTwits
12/28/2018Cantor FitzgeraldSet Price TargetInvesco DWA Utilities Momentum ETF (PTE)Buy $65.00LowView Rating Details  Share on Twitter  Share on StockTwits
12/28/2018Cantor FitzgeraldSet Price TargetANI Pharmaceuticals (ANIP)Buy $74.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/28/2018Cantor FitzgeraldSet Price TargetDermira (DERM)Buy $20.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/30/2018Cantor FitzgeraldSet Price TargetPfizer (PFE)Buy $53.00LowView Rating Details  Share on Twitter  Share on StockTwits
12/27/2018Cantor FitzgeraldInitiatesTAIWAN LIPOSOME/S (TLC)Overweight $11.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/26/2018Cantor FitzgeraldReiteratesAridis Pharmaceuticals (ARDS)Buy $25.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/24/2018Cantor FitzgeraldSet Price TargetAcorda Therapeutics (ACOR)Hold ACOR $32.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/20/2018Cantor FitzgeraldSet Price TargetShire (SHPG)Buy $222.00LowView Rating Details  Share on Twitter  Share on StockTwits
12/20/2018Cantor FitzgeraldSet Price TargetPerrigo (PRGO)Buy PRGO $107.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/20/2018Cantor FitzgeraldSet Price TargetViewray (VRAY)Buy $13.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/21/2018Cantor FitzgeraldSet Price TargetAclaris Therapeutics (ACRS)Buy $50.00MediumView Rating Details  Share on Twitter  Share on StockTwits
12/21/2018Cantor FitzgeraldSet Price TargetAmarin (AMRN)Buy $35.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/20/2018Cantor FitzgeraldReiteratesDeciphera Pharmaceuticals (DCPH)Buy $53.00MediumView Rating Details  Share on Twitter  Share on StockTwits
12/20/2018Cantor FitzgeraldReiteratesApellis Pharmaceuticals (APLS)Buy $53.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/19/2018Cantor FitzgeraldReiteratesKrystal Biotech (KRYS)Buy $34.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/19/2018Cantor FitzgeraldReiteratesAxoGen (AXGN)Buy $43.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/19/2018Cantor FitzgeraldDowngradesHi-Crush Partners (HCLP)Neutral -> UnderweightHighView Rating Details  Share on Twitter  Share on StockTwits
12/19/2018Cantor FitzgeraldLowers TargetFactSet Research Systems (FDS)Neutral $209.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/19/2018Cantor FitzgeraldReiteratesGilead Sciences (GILD)Overweight $92.00MediumView Rating Details  Share on Twitter  Share on StockTwits
12/19/2018Cantor FitzgeraldInitiatesGALAPAGOS NV/S (GLPG)Overweight -> Overweight $130.00MediumView Rating Details  Share on Twitter  Share on StockTwits
12/18/2018Cantor FitzgeraldReiteratesCerus (CERS)Buy $9.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/18/2018Cantor FitzgeraldRaises TargetPuma Biotechnology (PBYI) $55.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/17/2018Cantor FitzgeraldReiteratesCastlight Health (CSLT)Buy $5.00MediumView Rating Details  Share on Twitter  Share on StockTwits
12/17/2018Cantor FitzgeraldUpgradesHealthequity (HQY)Neutral -> Overweight $82.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/17/2018Cantor FitzgeraldSet Price TargetZynerba Pharmaceuticals (ZYNE)Buy $21.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/17/2018Cantor FitzgeraldSet Price TargetOvid Therapeutics (OVID)Buy $10.00MediumView Rating Details  Share on Twitter  Share on StockTwits
12/17/2018Cantor FitzgeraldReiteratesVertex Pharmaceuticals (VRTX)Buy $217.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/17/2018Cantor FitzgeraldReiteratesWellCare Health Plans (WCG)Buy $330.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/17/2018Cantor FitzgeraldRaises TargetCentene (CNC)Overweight -> Overweight$145.00 -> $165.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/17/2018Cantor FitzgeraldReiteratesEvofem Biosciences (EVFM)Buy $9.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/17/2018Cantor FitzgeraldReiteratesProteostasis Therapeutics (PTI)Buy $21.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/17/2018Cantor FitzgeraldLowers TargetTivity Health (TVTY)Overweight -> Overweight$52.00 -> $49.00LowView Rating Details  Share on Twitter  Share on StockTwits
12/17/2018Cantor FitzgeraldSet Price TargetVanda Pharmaceuticals (VNDA)Buy $43.00MediumView Rating Details  Share on Twitter  Share on StockTwits
12/16/2018Cantor FitzgeraldReiteratesInternational Money Express (IMXI)Buy $15.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/14/2018Cantor FitzgeraldReiteratesKalvista Pharmaceuticals (KALV)Buy $32.00LowView Rating Details  Share on Twitter  Share on StockTwits
12/14/2018Cantor FitzgeraldSet Price TargetSupernus Pharmaceuticals (SUPN)Buy $57.00MediumView Rating Details  Share on Twitter  Share on StockTwits
12/14/2018Cantor FitzgeraldReiteratesAmarin (AMRN)Buy $35.00MediumView Rating Details  Share on Twitter  Share on StockTwits
12/13/2018Cantor FitzgeraldReiteratesCentene (CNC)Buy $145.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/13/2018Cantor FitzgeraldSet Price TargetCatalyst Pharmaceuticals (CPRX)Buy $9.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/13/2018Cantor FitzgeraldReiteratesAccenture (ACN)Buy $193.00LowView Rating Details  Share on Twitter  Share on StockTwits
12/13/2018Cantor FitzgeraldReiteratesProQR Therapeutics (PRQR)Buy $40.00MediumView Rating Details  Share on Twitter  Share on StockTwits
12/13/2018Cantor FitzgeraldSet Price TargetEmergent Biosolutions (EBS)Buy $75.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/13/2018Cantor FitzgeraldReiteratesBioDelivery Sciences International (BDSI)Buy $5.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/13/2018Cantor FitzgeraldSet Price TargetAimmune Therapeutics (AIMT)Buy $64.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/12/2018Cantor FitzgeraldReiteratesBiogen (BIIB)Buy $400.00LowView Rating Details  Share on Twitter  Share on StockTwits
12/12/2018Cantor FitzgeraldReiteratesNeurocrine Biosciences (NBIX)Buy $121.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/11/2018Cantor FitzgeraldSet Price TargetArrowhead Pharmaceuticals (ARWR)Buy $24.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/12/2018Cantor FitzgeraldUpgradesCorcept Therapeutics (CORT)Neutral -> Overweight$17.00 -> $29.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/11/2018Cantor FitzgeraldReiteratesPfizer (PFE)Buy $53.00LowView Rating Details  Share on Twitter  Share on StockTwits
12/11/2018Cantor FitzgeraldReiteratesAcelRx Pharmaceuticals (ACRX)Buy $9.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/11/2018Cantor FitzgeraldSet Price TargetIntra-Cellular Therapies (ITCI)Buy $32.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/10/2018Cantor FitzgeraldSet Price TargetBiohaven Pharmaceutical (BHVN)Buy $65.00LowView Rating Details  Share on Twitter  Share on StockTwits
12/10/2018Cantor FitzgeraldReiteratesCerus (CERS)Buy $9.00LowView Rating Details  Share on Twitter  Share on StockTwits
12/10/2018Cantor FitzgeraldSet Price TargetVanda Pharmaceuticals (VNDA)Buy $43.00LowView Rating Details  Share on Twitter  Share on StockTwits
12/10/2018Cantor FitzgeraldSet Price TargetAxsome Therapeutics (AXSM)Buy $16.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/10/2018Cantor FitzgeraldSet Price TargetMarinus Pharmaceuticals (MRNS)Buy $25.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/10/2018Cantor FitzgeraldReiteratesWright Medical Group (WMGI)Buy $35.00MediumView Rating Details  Share on Twitter  Share on StockTwits
12/9/2018Cantor FitzgeraldInitiatesAimmune Therapeutics (AIMT)Overweight$64.00 -> $23.75LowView Rating Details  Share on Twitter  Share on StockTwits
12/9/2018Cantor FitzgeraldLowers TargetGW Pharmaceuticals PLC- (GWPH)$211.00 -> $193.00LowView Rating Details  Share on Twitter  Share on StockTwits
12/7/2018Cantor FitzgeraldReiteratesAmarin (AMRN)Buy $35.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/7/2018Cantor FitzgeraldReiteratesAlnylam Pharmaceuticals (ALNY)Buy $135.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/7/2018Cantor FitzgeraldReiteratesDenali Therapeutics (DNLI)Buy $25.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/7/2018Cantor FitzgeraldSet Price TargetSpring Bank Pharmaceuticals (SBPH)Buy $34.00LowView Rating Details  Share on Twitter  Share on StockTwits
12/6/2018Cantor FitzgeraldReiteratesOmnicell (OMCL)Overweight -> Overweight$70.00 -> $80.00LowView Rating Details  Share on Twitter  Share on StockTwits
12/6/2018Cantor FitzgeraldReiteratesNextgen Healthcare (NXGN)Buy $23.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/6/2018Cantor FitzgeraldReiteratesVerisk Analytics (VRSK)Buy $135.00MediumView Rating Details  Share on Twitter  Share on StockTwits
12/6/2018Cantor FitzgeraldReiteratesOvid Therapeutics (OVID)Buy $10.00MediumView Rating Details  Share on Twitter  Share on StockTwits
12/6/2018Cantor FitzgeraldReiteratesAbeona Therapeutics (ABEO)Buy $36.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/6/2018Cantor FitzgeraldReiteratesIntercept Pharmaceuticals (ICPT)Buy $170.00LowView Rating Details  Share on Twitter  Share on StockTwits
12/6/2018Cantor FitzgeraldRaises TargetHealthequity (HQY)Neutral -> Neutral$80.00 -> $82.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/5/2018Cantor FitzgeraldSet Price TargetNeurocrine Biosciences (NBIX)Buy $150.00LowView Rating Details  Share on Twitter  Share on StockTwits
12/6/2018Cantor FitzgeraldReiteratesViewray (VRAY)Buy $13.00MediumView Rating Details  Share on Twitter  Share on StockTwits
12/5/2018Cantor FitzgeraldReiteratesACADIA Pharmaceuticals (ACAD)Buy $30.00LowView Rating Details  Share on Twitter  Share on StockTwits
12/5/2018Cantor FitzgeraldReiteratesHalozyme Therapeutics (HALO)Buy $27.00LowView Rating Details  Share on Twitter  Share on StockTwits
12/5/2018Cantor FitzgeraldSet Price TargetZynerba Pharmaceuticals (ZYNE)Buy $21.00MediumView Rating Details  Share on Twitter  Share on StockTwits
12/5/2018Cantor FitzgeraldReiteratesCytokinetics (CYTK)Buy $14.00LowView Rating Details  Share on Twitter  Share on StockTwits
12/5/2018Cantor FitzgeraldDowngradesTESARO (TSRO)Overweight -> NeutralLowView Rating Details  Share on Twitter  Share on StockTwits
12/4/2018Cantor FitzgeraldReiteratesAmgen (AMGN)Neutral $223.00MediumView Rating Details  Share on Twitter  Share on StockTwits
12/4/2018Cantor FitzgeraldSet Price TargetMarinus Pharmaceuticals (MRNS)Buy $19.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/4/2018Cantor FitzgeraldReiteratesGW Pharmaceuticals PLC- (GWPH)OverweightLowView Rating Details  Share on Twitter  Share on StockTwits
12/3/2018Cantor FitzgeraldSet Price TargetRigel Pharmaceuticals (RIGL)Buy $9.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/4/2018Cantor FitzgeraldUpgradesVanda Pharmaceuticals (VNDA)Neutral -> Overweight $43.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/3/2018Cantor FitzgeraldReiteratesAnthem (ANTM)Overweight -> Buy$305.00 -> $330.00MediumView Rating Details  Share on Twitter  Share on StockTwits
12/3/2018Cantor FitzgeraldSet Price TargetSpark Therapeutics (ONCE)Buy $103.00MediumView Rating Details  Share on Twitter  Share on StockTwits
12/3/2018Cantor FitzgeraldSet Price TargetAnaptysBio (ANAB)Buy $140.00MediumView Rating Details  Share on Twitter  Share on StockTwits
12/3/2018Cantor FitzgeraldReiteratesAptinyx (APTX)Buy $40.00LowView Rating Details  Share on Twitter  Share on StockTwits
12/3/2018Cantor FitzgeraldReiteratesBiohaven Pharmaceutical (BHVN)Buy $65.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/3/2018Cantor FitzgeraldRaises TargetOcular Therapeutix (OCUL)Overweight -> Overweight$22.00 -> $24.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/3/2018Cantor FitzgeraldSet Price TargetGlobal Blood Therapeutics (GBT)Buy $96.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/2/2018Cantor FitzgeraldSet Price TargetWorkday (WDAY)Buy $185.00LowView Rating Details  Share on Twitter  Share on StockTwits
12/3/2018Cantor FitzgeraldLowers TargetGW Pharmaceuticals PLC- (GWPH)Overweight -> Buy$211.00 -> $193.00MediumView Rating Details  Share on Twitter  Share on StockTwits
12/3/2018Cantor FitzgeraldSet Price TargetApellis Pharmaceuticals (APLS)Buy $53.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/3/2018Cantor FitzgeraldReiteratesbluebird bio (BLUE)Hold $134.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/3/2018Cantor FitzgeraldSet Price TargetKindred Biosciences (KIN)Buy $25.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/2/2018Cantor FitzgeraldInitiatesAimmune Therapeutics (AIMT)Buy $64.00LowView Rating Details  Share on Twitter  Share on StockTwits
12/2/2018Cantor FitzgeraldInitiatesCVS Health (CVS)Overweight$96.00 -> $77.84LowView Rating Details  Share on Twitter  Share on StockTwits
11/30/2018Cantor FitzgeraldReiteratesGlobant (GLOB)Hold $57.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/30/2018Cantor FitzgeraldSet Price TargetProQR Therapeutics (PRQR)Buy $40.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/30/2018Cantor FitzgeraldSet Price TargetCollegium Pharmaceutical (COLL)Buy $35.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/28/2018Cantor FitzgeraldSet Price TargetBioMarin Pharmaceutical (BMRN)Buy $126.00MediumView Rating Details  Share on Twitter  Share on StockTwits
11/28/2018Cantor FitzgeraldSet Price TargetCatalyst Pharmaceuticals (CPRX)Buy $8.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/26/2018Cantor FitzgeraldReiteratesOptiNose (OPTN)OverweightLowView Rating Details  Share on Twitter  Share on StockTwits
11/27/2018Cantor FitzgeraldSet Price TargetGW Pharmaceuticals PLC- (GWPH)Buy $211.00MediumView Rating Details  Share on Twitter  Share on StockTwits
11/23/2018Cantor FitzgeraldReiteratesXencor (XNCR)OverweightHighView Rating Details  Share on Twitter  Share on StockTwits
11/23/2018Cantor FitzgeraldReiteratesTherapeuticsMD (TXMD)OverweightHighView Rating Details  Share on Twitter  Share on StockTwits
11/23/2018Cantor FitzgeraldReiteratesSupernus Pharmaceuticals (SUPN)OverweightHighView Rating Details  Share on Twitter  Share on StockTwits
11/23/2018Cantor FitzgeraldReiteratesProthena (PRTA)OverweightHighView Rating Details  Share on Twitter  Share on StockTwits
11/23/2018Cantor FitzgeraldReiteratesNovavax (NVAX)NeutralHighView Rating Details  Share on Twitter  Share on StockTwits
11/23/2018Cantor FitzgeraldReiteratesSeres Therapeutics (MCRB)OverweightHighView Rating Details  Share on Twitter  Share on StockTwits
11/23/2018Cantor FitzgeraldReiteratesEvofem Biosciences (EVFM)OverweightLowView Rating Details  Share on Twitter  Share on StockTwits
11/23/2018Cantor FitzgeraldReiteratesCymaBay Therapeutics (CBAY)OverweightHighView Rating Details  Share on Twitter  Share on StockTwits
11/23/2018Cantor FitzgeraldReiteratesArena Pharmaceuticals (ARNA)OverweightHighView Rating Details  Share on Twitter  Share on StockTwits
11/23/2018Cantor FitzgeraldReiteratesAMAG Pharmaceuticals (AMAG)NeutralHighView Rating Details  Share on Twitter  Share on StockTwits
11/23/2018Cantor FitzgeraldReiteratesAimmune Therapeutics (AIMT)OverweightLowView Rating Details  Share on Twitter  Share on StockTwits
11/27/2018Cantor FitzgeraldReiteratesVertex Pharmaceuticals (VRTX)Buy $217.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/26/2018Cantor FitzgeraldSet Price TargetHalozyme Therapeutics (HALO)Buy $27.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/27/2018Cantor FitzgeraldSet Price TargetBiohaven Pharmaceutical (BHVN)Overweight -> Buy $55.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/26/2018Cantor FitzgeraldInitiatesCVS Health (CVS)Overweight $96.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/26/2018Cantor FitzgeraldReiteratesSarepta Therapeutics (SRPT)Buy $217.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/21/2018Cantor FitzgeraldReiteratesUnitedHealth Group (UNH)Buy $310.00MediumView Rating Details  Share on Twitter  Share on StockTwits
11/20/2018Cantor FitzgeraldReiteratesMylan (MYL)Hold $41.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/14/2018Cantor FitzgeraldReiteratesProQR Therapeutics (PRQR)OverweightLowView Rating Details  Share on Twitter  Share on StockTwits
11/19/2018Cantor FitzgeraldSet Price TargetNovavax (NVAX)Hold $2.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/19/2018Cantor FitzgeraldSet Price TargetCorcept Therapeutics (CORT)Hold $17.00MediumView Rating Details  Share on Twitter  Share on StockTwits
11/19/2018Cantor FitzgeraldReiteratesPfizer (PFE)Buy $53.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/19/2018Cantor FitzgeraldReiteratesRoyal Mail (ROYMF)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
11/19/2018Cantor FitzgeraldReiteratesTESARO (TSRO)Buy $68.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/16/2018Cantor FitzgeraldReiteratesHealth Insurance Innovations (HIIQ)Buy $65.00MediumView Rating Details  Share on Twitter  Share on StockTwits
11/16/2018Cantor FitzgeraldUpgradesNorthern Dynasty Minerals (NAK)Hold -> BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
11/16/2018Cantor FitzgeraldReiteratesAcadia Healthcare (ACHC)Hold $39.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/15/2018Cantor FitzgeraldReiteratesEvofem Biosciences (EVFM)Buy $9.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/15/2018Cantor FitzgeraldSet Price TargetArena Pharmaceuticals (ARNA)Buy $65.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/15/2018Cantor FitzgeraldLowers TargetBiohaven Pharmaceutical (BHVN)Overweight -> Buy$57.00 -> $55.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/15/2018Cantor FitzgeraldReiteratesUniqure (QURE)Buy $65.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/15/2018Cantor FitzgeraldReiteratesLuxoft (LXFT)Buy $52.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/15/2018Cantor FitzgeraldInitiatesAxsome Therapeutics (AXSM)Overweight $16.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/14/2018Cantor FitzgeraldInitiatesAptinyx (APTX)Overweight -> Overweight $40.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/14/2018Cantor FitzgeraldInitiatesOvid Therapeutics (OVID)OverweightMediumView Rating Details  Share on Twitter  Share on StockTwits
11/14/2018Cantor FitzgeraldInitiatesDenali Therapeutics (DNLI)Overweight -> Overweight $25.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/14/2018Cantor FitzgeraldInitiatesOtonomy (OTIC)Overweight $9.00MediumView Rating Details  Share on Twitter  Share on StockTwits
11/14/2018Cantor FitzgeraldDowngradesFive Star Senior Living (FVE)Overweight -> NeutralMediumView Rating Details  Share on Twitter  Share on StockTwits
11/14/2018Cantor FitzgeraldReiteratesAldeyra Therapeutics (ALDX)Buy $30.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/13/2018Cantor FitzgeraldSet Price TargetGlobus Medical (GMED)Buy $65.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/14/2018Cantor FitzgeraldSet Price TargetRA Medical Systems (RMED)Buy $21.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/14/2018Cantor FitzgeraldLowers TargetOptiNose (OPTN)Overweight -> Overweight$30.00 -> $27.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/13/2018Cantor FitzgeraldInitiatesProQR Therapeutics (PRQR)Buy $40.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/13/2018Cantor FitzgeraldReiteratesAridis Pharmaceuticals (ARDS)Buy $25.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/13/2018Cantor FitzgeraldSet Price TargetAMAG Pharmaceuticals (AMAG)Hold $18.00MediumView Rating Details  Share on Twitter  Share on StockTwits
11/12/2018Cantor FitzgeraldSet Price TargetAbeona Therapeutics (ABEO)Buy $36.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/12/2018Cantor FitzgeraldSet Price TargetKalvista Pharmaceuticals (KALV)Buy $32.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/12/2018Cantor FitzgeraldSet Price TargetAimmune Therapeutics (AIMT)Buy $62.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/12/2018Cantor FitzgeraldLowers TargetPTC Therapeutics (PTCT)Overweight -> Overweight$66.00 -> $61.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/11/2018Cantor FitzgeraldSet Price TargetMesoblast (MESO)Buy $23.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/12/2018Cantor FitzgeraldSet Price TargetApellis Pharmaceuticals (APLS)Buy $53.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/12/2018Cantor FitzgeraldDowngradesPacific Biosciences of California (PACB)Overweight -> Neutral $8.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/9/2018Cantor FitzgeraldReiteratesTheravance Biopharma (TBPH)Buy $55.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/9/2018Cantor FitzgeraldSet Price TargetAnaptysBio (ANAB)Buy $140.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/9/2018Cantor FitzgeraldReiteratesTESARO (TSRO)Buy $68.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/9/2018Cantor FitzgeraldReiteratesNeos Therapeutics (NEOS)Buy $20.00MediumView Rating Details  Share on Twitter  Share on StockTwits
11/8/2018Cantor FitzgeraldSet Price TargetSeres Therapeutics (MCRB)Buy $15.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/9/2018Cantor FitzgeraldReiteratesHTG Molecular Diagnostics (HTGM)Buy $7.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/8/2018Cantor FitzgeraldReiteratesCollegium Pharmaceutical (COLL)Buy $35.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/8/2018Cantor FitzgeraldReiteratesNational Health Investors (NHI)Hold $80.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/8/2018Cantor FitzgeraldSet Price TargetCatalyst Pharmaceuticals (CPRX)Buy $8.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/8/2018Cantor FitzgeraldSet Price TargetPfizer (PFE)Buy $53.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/8/2018Cantor FitzgeraldReiteratesAlnylam Pharmaceuticals (ALNY)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
11/8/2018Cantor FitzgeraldReiteratesSquare (SQ)Overweight$76.00 -> $91.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/7/2018Cantor FitzgeraldSet Price TargetTherapeuticsMD (TXMD)Buy $27.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/7/2018Cantor FitzgeraldReiteratesArena Pharmaceuticals (ARNA)Buy $65.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/7/2018Cantor FitzgeraldReiteratesDermira (DERM)Buy $20.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/7/2018Cantor FitzgeraldReiteratesGenesis Healthcare (GEN)Buy $7.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/7/2018Cantor FitzgeraldReiteratesMenlo Therapeutics (MNLO)Buy $25.00MediumView Rating Details  Share on Twitter  Share on StockTwits
11/7/2018Cantor FitzgeraldSet Price TargetEvofem Biosciences (EVFM)Buy $9.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/7/2018Cantor FitzgeraldReiteratesIntra-Cellular Therapies (ITCI)Buy $32.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/7/2018Cantor FitzgeraldSet Price TargetReata Pharmaceuticals (RETA)Buy $100.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/7/2018Cantor FitzgeraldSet Price TargetMomenta Pharmaceuticals (MNTA)Hold $16.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/7/2018Cantor FitzgeraldDowngradesAAC (AAC)Overweight -> Neutral $4.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/6/2018Cantor FitzgeraldSet Price TargetHalozyme Therapeutics (HALO)Buy $27.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/7/2018Cantor FitzgeraldSet Price TargetACADIA Pharmaceuticals (ACAD)Buy $30.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/7/2018Cantor FitzgeraldSet Price TargetCymaBay Therapeutics (CBAY)Buy $17.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/7/2018Cantor FitzgeraldSet Price TargetCara Therapeutics (CARA)Buy $27.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/7/2018Cantor FitzgeraldSet Price TargetSupernus Pharmaceuticals (SUPN)Buy $57.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/7/2018Cantor FitzgeraldReiteratesGenpact (G)Buy $36.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/7/2018Cantor FitzgeraldReiteratesDXC Technology (DXC)Hold $70.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/6/2018Cantor FitzgeraldReiteratesAclaris Therapeutics (ACRS)Buy $50.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/6/2018Cantor FitzgeraldReiteratesJazz Pharmaceuticals (JAZZ)Buy $201.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/6/2018Cantor FitzgeraldInitiatesProteostasis Therapeutics (PTI)Buy $21.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/6/2018Cantor FitzgeraldReiteratesBausch Health Companies (BHC)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
11/6/2018Cantor FitzgeraldSet Price TargetANI Pharmaceuticals (ANIP)Buy $74.00MediumView Rating Details  Share on Twitter  Share on StockTwits
11/6/2018Cantor FitzgeraldReiteratesTabula Rasa HealthCare (TRHC)Buy $99.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/6/2018Cantor FitzgeraldSet Price TargetSpark Therapeutics (ONCE)Buy $103.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/6/2018Cantor FitzgeraldReiteratesXencor (XNCR)Buy $40.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/5/2018Cantor FitzgeraldSet Price TargetNeurocrine Biosciences (NBIX)Buy $150.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/6/2018Cantor FitzgeraldSet Price TargetAlder Biopharmaceuticals (ALDR)Hold $21.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/5/2018Cantor FitzgeraldReiteratesTivity Health (TVTY)Buy $49.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/5/2018Cantor FitzgeraldReiteratesMylan (MYL)Hold $41.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/5/2018Cantor FitzgeraldReiteratesAlkermes (ALKS)Neutral -> Neutral$46.00 -> $41.00HighView Rating Details  Share on Twitter  Share on StockTwits

This page was last refreshed on Tuesday at 03:05 AM ET.

MarketBeat Community Rating for Cantor Fitzgerald

Community Ranking:  1.6 out of 5 (star half star)
Outperform Votes:  9,692 (Vote Outperform)
Underperform Votes:  19,695 (Vote Underperform)
Total Votes:  29,387
MarketBeat's community ratings are surveys of what our community members think about Cantor Fitzgerald and other research firms. Vote "Outperform" if you believe Cantor Fitzgerald's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Cantor Fitzgerald's recmomendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel